| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:00 PM | -$2.06 | -$1.99GAAP | +3.4% | -28% | — | $0 | — | — | |
| Q2 '26 | 8/5/264:05 PM | -$1.97 | -$1.97GAAP | 0.0% | -61% | $12.5M | $0 | ⚠ Check | — | |
| Q1 '26 | 5/6/264:00 PM | -$1.79 | -$2.30GAAP | -28.5% | -121% | $12.5M | $0 | ⚠ Check | — | |
| Q4 '25 | 2/24/264:00 PM | -$1.49 | -$1.80GAAP | -20.8% | -76% | — | $0 | — | — | |
| Q3 '25 | 11/4/254:00 PM | -$1.25 | -$1.56GAAP | -24.8% | -88% | — | $0 | — | — | |
| Q2 '25 | 8/6/254:05 PM | -$1.15 | -$1.22GAAP | -6.1% | -11% | — | $0 | — | — | |
| Q1 '25 | 5/7/254:00 PM | -$0.92 | -$1.04GAAP | -13.0% | -22% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC.